Simultaneously inhibition of HIV and HBV replication through a dual small interfering RNA expression system

Antiviral Research

Volumn 74, Issue 2, 2007, Pages 142-149

  Wu, Kailang ^a   Mu, Yongxin ^a   Hu, Jing ^a   Lu, Lu ^a   Zhang, Xue ^a   Yang, Yongbo ^a   Li, Yan ^a   Liu, Fang ^a   Song, Degui ^a   Zhu, Ying ^a   Wu, Jianguo ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Dual siRNA; HBV; HIV; Viral replication

Indexed keywords

GLYCOPROTEIN GP 120; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; DRUG MECHANISM; GENE EXPRESSION SYSTEM; GENE SILENCING; GENE TARGETING; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RNA INTERFERENCE; VIRUS GENE; VIRUS INHIBITION; VIRUS TRANSMISSION;

ANIMALS; ANTI-HIV AGENTS; ANTIVIRAL AGENTS; CELL LINE; CERCOPITHECUS AETHIOPS; GENES, REPORTER; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HIV; HIV ENVELOPE PROTEIN GP120; HUMANS; LUCIFERASES; RNA, MESSENGER; RNA, SMALL INTERFERING; RNA, VIRAL; VIRUS REPLICATION;

ANIMALIA; HEPATITIS B VIRUS; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 33947255461     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2006.11.004     Document Type: Article

References (29)

1. Beasley R.P. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 61 (1988) 1942-1956
2. Benhamou Y., Bochet M., Di Martino V., Charlotte F., Azria F., Coutellier A., Vidaud M., Bricaire F., Opolon P., Katlama C., and Poynard T. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology 30 (1999) 1054-1058
3. Brummelkamp T.R., Bernards R., and Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 296 (2002) 550-553
4. Capodici J., Kariko K., and Weissman D. Inhibition of HIV-1 infection by small interferring RNA-mediated RNA interference. J. Immunol. 169 (2002) 5196-5201
5. Cioca D.P., Aoki Y., and Kiyosawa K. RNA interference is a functional pathway with therapeutic potential in human myeloid leukemia cell lines. Cancer Gene Ther. 10 (2003) 125-133
6. Coburn G.A., and Cullen B.R. Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference. J. Virol. 76 (2002) 9225-9231
7. Colin J.F., Cazals-Hatem D., Loriot M.A., Martinot-Peignoux M., Pham B.N., Auperin A., Degott C., Benhamou J.P., Erlinger S., Valla D., and Marcellin P. Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men. Hepatology 29 (1999) 1306-1310
8. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., and Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411 (2001) 494-498
9. Fire A., Xu S., Montgomery M.K., Kostas S.A., Driver S.E., and Mello C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391 (1998) 806-811
10. Gitlin L., Karelsky S., and Andino R. Short interfering RNA confers intracellular antiviral immunity in human cells. Nature 418 (2002) 430-434
11. Gómez-Gonzalo M., Carretero M., Rullas J., Lara-Pezzi E., Aramburu J., Berkhout B., Alcami J., and Lopez-Cabrera M. The hepatitis B virus X protein induces HIV-1 replication and transcription in synergy with T-cell activation signals: functional roles of NK-kappaB/NF-AT and SP1-binding sites in the HIV-1 long terminal repeat promoter. J. Biol. Chem. 276 (2001) 35435-43443
12. Hadler S.C., Judson F.N., O'Malley P.M., Altman N.L., Penley K., Buchbinder S., Schable C.A., Coleman P.J., Ostrow D.N., and Francis D.P. Outcome of hepatitis B virus infection in homosexual men and its relation to prior human immunodeficiency virus infection. J. Infect. Dis. 163 (1991) 454-459
13. Hamasaki K., Nakao K., Matsumoto K., Ichikawa T., Ishikawa H., and Eguchi K. Short interfering RNA-directed inhibition of hepatitis B virus replication. FEBS Lett. 543 (2003) 51-54
14. He M.L., Zheng B., Peng Y., Peiris J.S., Poon L.L., Yuen K.Y., Lin M.C., Kung H.F., and Guan Y. Inhibition of SARS-associated coronavirus infection and replication by RNA interference. JAMA 290 (2003) 2665-2666
15. Hsu Y.S., Chien R.N., Yeh C.T., Sheen I.S., Chiou H.Y., Chu C.M., and Liaw Y.F. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology 35 (2002) 1522-1527
16. Hu W.Y., Myers C.P., Kilzer J.M., Pfaff S.L., and Bushman F.D. Inhibition of retroviral pathogenesis by RNA interference. Curr. Biol. 12 (2002) 1301-1311
17. Jacque J.M., Triques K., and Stevenson M. Modulation of HIV-1 replication by RNA interference. Nature 418 (2002) 435-538
18. Kapadia S.B., Brideau-Andersen A., and Chisari F.V. Interference of hepatitis C virus RNA replication by short interfering RNAs. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 2014-2018
19. Lee N.S., Dohjima T., Bauer G., Li H., Li M.J., Ehsani A., Salvaterra P., and Rossi J. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat. Biotechnol. 20 (2002) 500-505
20. McCaffrey A.P., Nakai H., Pandey K., Huang Z., Salazar F.H., Xu H., Wieland S.F., Marion P.L., and Kay M.A. Inhibition of hepatitis B virus in mice by RNA interference. Nat. Biotechnol. 21 (2003) 639-644
21. McNair A.N., Main J., and Thomas H.C. Interactions of the human immunodeficiency virus and the hepatotropic viruses. Semin. Liver Dis. 12 (1992) 188-196
22. Paul C.P., Good P.D., Winer I., and Engelke D.R. Effective expression of small interfering RNA in human cells. Nat. Biotechnol. 20 (2002) 505-508
23. Peterlin B.M., and Luciw P.A. Molecular biology of HIV. AIDS 2 Suppl. 1 (1988) S29-S40
24. Pugh J.C., Yaginuma K., Koike K., and Summers J. Duck hepatitis B virus (DHBV) particles produced by transient expreesion of DHBV DNA in a human hepatoma cell line are infectious in vitro. J. Virol. 62 (1988) 3516-3531
25. Seeger C., and Mason W.S. Hepatitis B virus biology. Microbiol. Mol. Biol. Rev. 64 (2000) 51-68
26. Shlomai A., and Shaul Y. Inhibition of hepatitis B virus expression and replication by RNA interference. Hepatology 37 (2003) 764-770
27. Verma U.N., Surabhi R.M., Schmaltieg A., Becerra C., and Gaynor R.B. Small interfering RNAs directed against beta-catenin inhibit the in vitro and in vivo growth of colon cancer cells. Clin. Cancer Res. 9 4 (2003) 1291-1300
28. Wu K.L., Zhang X., Zhang J., Yang Y., Mu Y.X., Liu M., Lu L., Li Y., Zhu Y., and Wu J. Inhibition of hepatitis B virus gene expression by single and dual small interfering RNA treatment. Virus Res. 112 (2005) 100-107
29. Zhang L., Yang N., Mohamed-Hadley A., Rubin S.C., and Coukos G. Vector based RNAi; a novel tool for isoform-specific knock-down of VEGF and anti-angiogenesis gene therapy of cancer. Biochem. Biophys. Res. Commun. 303 (2003) 1169-1178